Abstract
Purpose
Oxidative stress in chronic hyperglycemia could injure the tissues and onset of diabetes-related complications like retinopathy and neuropathy. This study investigates the association between methylenetetrahydrofolate reductase (MTHFR) and glutathione peroxidase (GPx) genetic variants with these complications.
Methods
In this case-control study, 400 individuals, including 100 healthy subjects and 300 patients with type 2 diabetes mellitus (T2DM) in three subgroups: with retinopathy(n = 100), with neuropathy(n = 100), and without complication (n = 100) from West Iran, were studied. MTHFR (rs1801133) and GPx-1 (rs1050450) variants were identified by the PCR-RFLP method. The plasma levels of GPx activity, glutathione, malondialdehyde (MDA), total antioxidant capacity (TAC), and total oxidative stress (TOS) were measured by chemical methods.
Results
Higher BMI, TOS and MDA levels were observed in patients with neuropathy compared to other patients and controls. Diabetic patients with neuropathy had lower levels of glutathione (7.8 ± 4.5; P < 0.001), GPx activity (39.5 ± 8.5; P < 0.001), and TAC (703.1 ± 129.1; P = 0.0001) in comparison with other groups. The patients without complication and retinopathic patients had higher plasma levels of glutathione (12.2 ± 2.4; p = 0.02) and TAC (793.4 ± 124.6; P < 0.001), respectively. MTHFR TT genotype significantly correlated with lower levels of TOS (3.5 ± 1.1; P < 0.001) and OSI (0.0050 ± 0.001; P < 0.001). Subjects with the GPx-1 TT genotype had higher levels of MDA (6.8 ± 2.5; P = 0.02) and lower levels of TOS (3.7 ± 1.6; P < 0.001), which is statistically significant. TT genotype of MTHFR was associated with 3.9 fold (95% CI 1.04–4.76; P = 0.0436) increased risk of neuropathy. Also, GPx-1 CT genotype increased the risk of retinopathy [OR = 2.7 (95% CI = 1.38–5.44; P = 0.0039)].
Conclusion
The MTHFR TT genotype increased the risk of neuropathy in diabetic patients significantly. The GPx-1 CT genotype is related to increased retinopathy risk among diabetic patients. Both MTHFR and Gpx-1 TT genotypes were associated with higher BMI levels.
Similar content being viewed by others
Data availability
The data of present work are available from the corresponding author on reasonable request.
References
Zhao Y, Zhu R, Wang D, Liu X (2019) Genetics of diabetic neuropathy: systematic review, meta-analysis and trial sequential analysis. Ann Clin Transl Neurol 6(10):1996–2013
Xu W, Qian Y, Zhao L (2015) Angiotensin-converting enzyme I/D polymorphism is a genetic biomarker of diabetic peripheral neuropathy: evidence from a meta-analysis. Int J Clin Exp Med 8(1):944–948
Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M (2018) Complications of diabetes 2017. J Diabetes Res 2018:3086167
Tuttolomondo A, Maida C, Pinto A (2015) Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. J Diabetes Res 2015:268390
Baum P, Toyka KV, Blüher M, Kosacka J, Nowicki M (2021) Inflammatory mechanisms in the pathophysiology of Diabetic Peripheral Neuropathy (DN)-New aspects. Int J Mol Sci. ;22(19)
Pathak D, Shrivastav D, Verma AK, Alsayegh AA, Yadav P, Khan NH et al (2022) Role of metabolizing MTHFR gene polymorphism (rs1801133) and its mRNA expression among type 2 diabetes. J Diabetes Metab Disord 21(1):511–516
Chen H, Wei F, Wang L, Wang Z, Meng J, Jia L et al (2015) MTHFR gene C677T polymorphism and type 2 diabetic nephropathy in Asian populations: a meta-analysis. Int J Clin Exp Med 8(3):3662–3670
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813–820
Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52(1):1–8
Kuzuya M, Ando F, Iguchi A, Shimokata H (2008) Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. Am J Clin Nutr 87(6):1939–1944
Beckett GJ, Arthur JR (2005) Selenium and endocrine systems. J Endocrinol 184(3):455–465
Heiran A, Azarchehry SP, Dehghankhalili S, Afarid M, Shaabani S, Mirahmadizadeh A (2022) Prevalence of diabetic retinopathy in the Eastern Mediterranean Region: a systematic review and meta-analysis. J Int Med Res 50(10):03000605221117134
Jin P, Peng J, Zou H, Wang W, Fu J, Shen B et al (2014) The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients. PLoS ONE 9(11):e113359
Manaviat MR, Rashidi M, Afkhami-Ardekani M (2008) Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes. Eur J Ophthalmol 18(4):572–577
Sadeghi A, Bayazidi Y, Davari M, Kebriaeezadeh A, Assarian A, Esteghamati A et al (2023) Individualized glycemic control in type 2 Diabetic patients in Iran: a Multi-center Data Analysis. Iran J Med Sci 48(3):286
Sadat Mahmoudi Nezhad G, Razeghinejad R, Janghorbani M, Mohamadian A, Hassan Jalalpour M, Bazdar S et al (2019) Prevalence, incidence and Ecological Determinants of Diabetic Retinopathy in Iran: systematic review and Meta-analysis. J Ophthalmic Vis Res 14(3):321–335
Baum P, Toyka KV, Blüher M, Kosacka J, Nowicki M (2021) Inflammatory mechanisms in the pathophysiology of diabetic peripheral neuropathy (DN)—new aspects. Int J Mol Sci 22(19):10835
Association AD (2023) Retinopathy, Neuropathy, and Foot Care: standards of Care in Diabetes—2023. Diabetes Care 46:S203–S15
Pang L, Lian X, Liu H, Zhang Y, Li Q, Cai Y et al (2020) Understanding diabetic neuropathy: focus on oxidative stress. Oxid Med Cell Longev 2020:1–13
Méndez-Morales S, Pérez-De Marcos J, Rodríguez-Cortés O, Flores-Mejía R, Martínez-Venegas M, Sánchez-Vera Y et al (2022) Diabetic neuropathy: molecular approach a treatment opportunity. Vascul Pharmacol 143:106954
Pang L, Lian X, Liu H, Zhang Y, Li Q, Cai Y et al (2020) Understanding Diabetic Neuropathy: focus on oxidative stress. Oxid Med Cell Longev 2020:9524635
Chen H, Wei F, Wang L, Wang Z, Meng J, Jia L et al (2015) MTHFR gene C677T polymorphism and type 2 diabetic nephropathy in Asian populations: a meta-analysis. Int J Clin Exp Med 8(3):3662
Zhou T-B, Drummen GP, Jiang Z-P, Li H-Y (2015) Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus. Ren Fail 37(8):1247–1259
Zidan AR, El Mougy HM, Moustafa HS, Mohamed EF (2019) Methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus. Sci J Al-Azhar Med Fac Girls 3(1):14–22
Kakavand Hamidi A, Radfar M, Amoli MM (2018) Association between MTHFR variant and diabetic neuropathy. Pharmacol Rep 70:1–5
El-Fatah A (2022) Assessment of Methylenetetrahydrofolate Reductase Gene Polymorphism in Diabetic Peripheral Neuropathy. Zagazig Univ Med J 28(61):272–279
Russo G, Giandalia A, Romeo EL, Scarcella C, Gambadoro N, Zingale R et al (2016) Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. J Endocrinol Invest 39:305–314
Bourgonje AR, Abdulle AE, Al-Rawas AM, Al-Maqbali M, Al-Saleh M, Enriquez MB et al (2020) Systemic oxidative stress is increased in postmenopausal women and independently associates with homocysteine levels. Int J Mol Sci 21(1):314
Sengupta S, Wehbe C, Majors AK, Ketterer ME, DiBello PM, Jacobsen DW (2001) Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation. J Biol Chem 276(50):46896–46904
Ismail LK, Abdel Rahman MF, Hashad IM, Abdel-Maksoud SM (2022) Contribution of glutathione peroxidase 1 (Pro200Leu) single nucleotide polymorphism and serum homocysteine levels in the risk of acute myocardial infarction in egyptians. J Genet Eng Biotechnol 20(1):1–7
Hamanishi T, Furuta H, Kato H, Doi A, Tamai M, Shimomura H et al (2004) Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes 53(9):2455–2460
Huang JQ, Zhou JC, Wu YY, Ren FZ, Lei XG (2018) Role of glutathione peroxidase 1 in glucose and lipid metabolism-related diseases. Free Radic Biol Med 127:108–115
Ahmad AA, Rahimi Z, Asadi S, Vaisi-Raygani A, Kohsari M (2023) The GPx-1 gene variants (rs1050450) in obesity: Association with the risk of obesity and the GPx activity in females. Rep Biochem Mol Biol 12(1):185–194
Huang X, Liu G, Guo J, Su Z (2018) The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 14(11):1483–1496
Buraczynska M, Buraczynska K, Dragan M, Ksiazek A (2017) Pro198Leu polymorphism in the glutathione peroxidase 1 gene contributes to diabetic peripheral neuropathy in type 2 diabetes patients. Neuromolecular Med 19:147–153
Albadawi N, Tarazawi E, Ismail A, Altoum S, Bakheet K (2017) Association 0f Gpx-198 C/T gene polymorphism (rs1050450-198 C/T) in Sudanese with Diabetic Retinopathy. J Blood Lymph 7(162):2
Acknowledgements
None.
Funding
Financially supported by Kermanshah University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
All authors contributed to designing the work; data acquisition; data analysis and interpretation of data; drafting and critically revision. All authors read and approved the final version of the manuscript and agree with all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The present study was approved by the ethics committee of Kermanshah University of Medical Science, Kermanshah, Iran (IR.KUMS.REC.1397.528.).
Informed consent
All participants had informed consent for the present work and after agreed to participate in the present study, their primary information were collected and recorded.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Asadi, S., Rahimi, Z., Kohsari, M. et al. Assessing the possible association between MTHFR (rs1801133) and GPx-1 (rs1050450) polymorphisms with the risk of type 2 diabetes, diabetic neuropathy, and diabetic retinopathy. Mol Biol Rep 51, 583 (2024). https://doi.org/10.1007/s11033-024-09519-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11033-024-09519-0